LifeArc

Funding rounds backed by LifeArc.

Export CSV
Funding disclosed in full
$174.8M
Median round
$87.4M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
RQ Bio

Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients

$115MSeries ABiotechUnited Kingdom
8 participantsEQT Life SciencesForbionFrazier Life SciencesLifeArcMonographOxford Science EnterprisesOxford University InnovationWellington Management
Exciva

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

€51MSeries BBiotechGermany
9 participantsAndera PartnersCarma FundEQT Life SciencesFountain Healthcare PartnersGimvLBBWLifeArcLSP Dementia FundModi Ventures